Brief: FDA Will Reverse Rejection Of Third Rare-Disease Drug, Regenxbio Says- WSJ
22/06/2026 11:45
BRIEF-FDA Will Reverse Rejection Of Third Rare-Disease Drug, Regenxbio Says- WSJ June 22 (Reuters) -
FDA WILL REVERSE REJECTION OF THIRD RARE-DISEASE DRUG, REGENXBIO SAYS- WSJ
Source https://tinyurl.com/4j272tfr
((Reuters.Briefs@thomsonreuters.com;))
Recent news on REGENXBIO
See all newsBrief: Regenxbio says Sarepta To Pay $39 Million To Regenxbio Within 10 Days Of Effective Date
Regenxbio climbs as new director buys nearly $1 million of stock
Brief: Regenxbio Strengthens Board Of Directors With Appointment Of Greg Ciongoli
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics